| Literature DB >> 34498299 |
Yan Wang1, Vanessa Hull1, Sarah Sternbach2, Brad Popovich3, Travis Burns1, Jennifer McDonough2, Fuzheng Guo1, David Pleasure1.
Abstract
Canavan disease is caused by ASPA mutations that diminish brain aspartoacylase activity, and it is characterized by excessive brain storage of the aspartoacylase substrate, N-acetyl-l-aspartate (NAA), and by astroglial and intramyelinic vacuolation. Astroglia and the arachnoid mater express sodium-dependent dicarboxylate transporter (NaDC3), encoded by SLC13A3, a sodium-coupled transporter for NAA and other dicarboxylates. Constitutive Slc13a3 deletion in aspartoacylase-deficient Canavan disease mice prevents brain NAA overaccumulation, ataxia, and brain vacuolation. ANN NEUROL 2021;90:845-850.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34498299 PMCID: PMC9549923 DOI: 10.1002/ana.26211
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 11.274